Document is current
Any future updates will be listed below
-
Authors
Brauneck, Elias
Leonhardt, Leon-Gordian
Assemissen, Anne Marie
Wahid, Yagana
Kruppa, Moritz
Kruppa, Niklas
Krüger, Julius
Menzel, Stephan
Koch-Nolte, Friedrich
Kylies, Julian
Weisel, Katja
Bokemeyer, Carsten
Wellbrock, Jasmin
Fiedler, Walter
Viezens, Lennart
Brauneck, Franziska
-
Funding
Funding for this research was provided by:
German Spine Foundation
Hamburger Krebshilfe
Mildred Scheel Nachwuchszentrum
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 2 February 2025
Accepted: 21 March 2025
First Online: 24 April 2025
Declarations
:
: BF: Travel grant Daiichi Sankyo, Servier, Novartis; advisory board by Jazz. GmbH, Daiichi Sankyo. FW: personal fees and non-financial support from AbbVie; grants, personal fees, and non-financial support from Amgen and Pfizer; and personal fees from Jazz Pharmaceuticals, Celgene, MorphoSys, Ariad/Incyte, stem line therapeutics Daiichi Sankyo, and Servier outside the submitted work; in addition, FW has a patent for Amgen issued; and support for medical writing: Amgen, Pfizer, AbbVie. The remaining authors declare that they have no conflict of interest. WJ: patent for Amgen issued. VL Speaker Fee from Johnson and Johnson.
: The study was approved by the local ethics board (PV5119 (Informed written consent was obtained from all patients) and PV2021-30031-WF (Informed consent was waived due to anonymization).
: Not applicable.
